(Total Views: 627)
Posted On: 01/22/2021 12:12:05 AM
Post# of 154098
........"Assessing the legal duty to use or disclose Interim data for ongoing Clinical Trials." Pages 51-84
---Journal of Law and the Bisciences.Pub. 13 August 2019 by Lisa Eckstein
DSMB Stopping Rules:
Stopping for Efficacy
Stopping for Inferiority
Stopping for Futility
Stopping for safety
A legal term is used; "Proof beyond.. reasonable doubt" strikes me as somewhat arbitrary..but, I'm not a lawyer...interesting case studies......Pfizer has an honorable, but dismissed mention.
---Journal of Law and the Bisciences.Pub. 13 August 2019 by Lisa Eckstein
DSMB Stopping Rules:
Stopping for Efficacy
Stopping for Inferiority
Stopping for Futility
Stopping for safety
A legal term is used; "Proof beyond.. reasonable doubt" strikes me as somewhat arbitrary..but, I'm not a lawyer...interesting case studies......Pfizer has an honorable, but dismissed mention.
(2)
(0)
